We are live on ! Find out more
NRX

NEPHROGENEX INC COM
NRX

Delisted

NRX was delisted on the 10th of May, 2016.

Back to rankings

17 hedge funds and large institutions have $1.15M invested in NEPHROGENEX INC COM in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

13% more funds holding

Funds holding: 15 → 17 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

76% less capital invested

Capital invested by funds: $4.89M → $1.15M (-$3.74M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
–
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$32.3K
2
Goldman Sachs
Goldman Sachs
New York
+$15.6K
3
UBS Group
UBS Group
Switzerland
+$7.13K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$107

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$941K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$23.2K
3
TRCT
Tower Research Capital (TRC)
New York
-$10K
4
VKH
Virtu KCG Holdings
New York
-$3.64K
5
Morgan Stanley
Morgan Stanley
New York
-$1.64K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCP
1
Rho Capital Partners
New York
$495K – – –
VAM
2
Visium Asset Management
New York
$371K – – –
BI
3
BVF Inc
California
$184K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$35K -$23.2K -27,912 -28%
Citadel Advisors
5
Citadel Advisors
Florida
$18K +$32.3K +38,899 New
JP Morgan Chase
6
JP Morgan Chase
New York
$15K – – –
VKH
7
Virtu KCG Holdings
New York
$12K -$3.64K -4,376 -15%
Goldman Sachs
8
Goldman Sachs
New York
$9K +$15.6K +18,736 New
BFA
9
BlackRock Fund Advisors
California
$7K -$1.09K -1,306 -8%
UBS Group
10
UBS Group
Switzerland
$4K +$7.13K +8,573 New
VIA
11
Vantage Investment Advisors
Pennsylvania
$2K – – –
Bank of America
12
Bank of America
North Carolina
$1K – – –
EWM
13
Edge Wealth Management
New York
$1K – – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$19 – – –
EC
15
EcoR1 Capital
California
– -$941K -588,235 Closed
TRCT
16
Tower Research Capital (TRC)
New York
– -$10K -6,179 Closed
Morgan Stanley
17
Morgan Stanley
New York
– -$1.64K -1,977 -99%
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– +$107 +129 New

NRX Hedge Fund Activity: Q1 2016 in Review

17 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NEPHROGENEX INC COM (NRX) for Q1 2016, worth a combined $1.15M — down 76% from $4.89M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NRX positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 4 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $32.3K. The largest seller was EcoR1 Capital, exiting entirely with an estimated $941K sold.

  • 17 institutional investors held NEPHROGENEX INC COM (NRX) as of Q1 2016, up from 15 in Q4 2015.
  • Funds reported $1.15M of NEPHROGENEX INC COM stock for Q1 2016, down 76% quarter-over-quarter.
  • 4 funds opened new NEPHROGENEX INC COM positions in Q1 2016 and 2 closed out, a net change of +2 holders.
  • The largest NEPHROGENEX INC COM buyer in Q1 2016 was Citadel Advisors, an estimated $32.3K added.
  • The largest NEPHROGENEX INC COM seller in Q1 2016 was EcoR1 Capital, an estimated $941K sold.

Based on aggregated 13F filings for Q1 2016.